Ezetimibe News
Ezetimibe currently has 0 news articles, with 20 predicted indications.
This page combines the AI-predicted indications for Ezetimibe with the latest health news. Indications highlighted in orange have recent news coverage.
Drug Information
- Original indication: Hypercholesterolaemia and mixed dyslipidaemiaNustendi is indicated in adults with primary hypercholesterolaemia (heterozygous familial and non-familial) or mixed dyslipidaemia, as an adjunct to...
- Evidence level: L5
- Predicted indications (20):
- homozygous familial hypercholesterolemia (99.9%)
- obsolete familial combined hyperlipidemia (99.7%)
- hyperlipoproteinemia (99.6%)
- familial hypercholesterolemia (99.4%)
- hypercholesterolemia due to cholesterol 7alpha-hydroxylase deficiency (99.2%)
- cholesterol-ester transfer protein deficiency (99.1%)
- hyperlipidemia, familial combined, LPL related (98.8%)
- HIV infectious disease (98.8%)
- hypercholesterolemia, autosomal dominant (98.8%)
- neurodevelopmental disorder with ataxic gait, absent speech, and decreased cortical white matter (98.7%)
- hyperlipidemia due to hepatic triglyceride lipase deficiency (98.6%)
- familial hyperlipidemia (98.4%)
- feline acquired immunodeficiency syndrome (98.1%)
- simian immunodeficiency virus infection (98.1%)
- hyperlipidemia (97.3%)
- hyperalphalipoproteinemia (97.2%)
- sitosterolemia (96.8%)
- familial chylomicronemia syndrome (95.5%)
- hypertriglyceridemia, familial (94.9%)
- hypolipoproteinemia (disease) (94.0%)
Related News (0)
No related news yet. When news mentions this drug, it will be collected and shown here automatically.
Disclaimer: The news on this page is collected automatically and is for research reference only; it does not constitute medical advice.